[Prognosis of periprosthetic regurgitation after mitral valve replacement using the Saint Jude prosthesis]

A Mahdhaoui1, M A Majdoub, H Bouraoui

  • 1Service de cardiologie, CHU Farhat-Hached, 4000 Sousse, Tunisie. abdallah.mahdhaoui@famso.rnu.tn

Annales De Cardiologie Et D'Angeiologie
|June 30, 2004
PubMed
Abstract

Insights

Mild periprosthetic regurgitation (PPR) after mitral valve replacement (MVR) is common and typically benign. This early postoperative complication, often detected by transesophageal echocardiography (TEE), usually resolves or remains clinically insignificant without specific treatment.

Area of Science:

  • Cardiovascular Surgery
  • Echocardiography
  • Prosthetic Valve Complications

Background:

  • Periprosthetic regurgitation (PPR) is a recognized complication following mitral valve replacement (MVR).
  • The management of mild and moderate PPR after MVR is not well-defined.
  • Early identification and characterization of PPR are crucial for patient outcomes.

Purpose of the Study:

  • To investigate the incidence, predictors, and natural history of PPR after MVR using St. Jude Medical (SJM) prostheses.
  • To evaluate the role of omniplane transesophageal echocardiography (TEE) in detecting early postoperative PPR.
  • To determine the clinical significance of mild and moderate PPR.

Main Methods:

  • Prospective study involving 56 patients undergoing MVR with SJM prostheses.
  • Early postoperative transesophageal echocardiography (TEE) was performed on average 14.7 days after surgery.
  • Analysis included incidence, jet characteristics, severity grading, and follow-up assessments at 6 weeks and 12.5 months.

Main Results:

  • The incidence of PPR was 59%, with most cases being minor (63%) or moderate (27%).
  • A prosthesis diameter/suture knot ratio greater than 1.7 was a significant predictor of PPR (OR=9, P=0.036).
  • PPR persisted in 90% at 6 weeks and 29% at 12.5 months, with no associated hemolytic anemia or heart failure.

Conclusions:

  • Mild and minor PPR are frequent early after MVR.
  • The clinical significance and natural history of these PPR cases appear benign.
  • No specific treatment is typically required for mild or minor PPR detected early post-MVR.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...